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Abstract
Background: Peroxisome proliferator-activated receptor γ (PPAR γ) is a nuclear receptor whose activation has been 
shown to modulate macrophage and T cell-mediated inflammation. The objective of this study was to investigate the 
mechanisms by which the deletion of PPAR γ in T cells modulates immune cell distribution and colonic gene 
expression and the severity of experimental IBD.
Methods: PPAR γ flfl; CD4 Cre+ (CD4cre) or Cre- (WT) mice were challenged with 2.5% dextran sodium sulfate in their 
drinking water for 0, 2, or 7 days. Mice were scored on disease severity both clinically and histopathologically. Flow 
cytometry was used to assess lymphocyte and macrophage populations in the blood, spleen, and mesenteric lymph 
nodes (MLN). Global gene expression in colonic mucosa was profiled using Affymetrix microarrays.
Results: The deficiency of PPAR γ in T cells accelerated the onset of disease and body weight loss. Examination of colon 
histopathology revealed significantly greater epithelial erosion, leukocyte infiltration, and mucosal thickening in the 
CD4cre mice on day 7. CD4cre mice had more CD8+ T cells than WT mice and fewer CD4+FoxP3+ regulatory T cells 
(Treg) and IL10+CD4+ T cells in blood and MLN, respectively. Transcriptomic profiling revealed around 3000 genes 
being transcriptionally altered as a result of DSS challenge in CD4cre mice. These included up-regulated mRNA 
expression of adhesion molecules, proinflammatory cytokines interleukin-6 (IL-6) and IL-1β, and suppressor of cytokine 
signaling 3 (SOCS-3) on day 7. Gene set enrichment analysis (GSEA) showed that the ribosome and Krebs cycle 
pathways were downregulated while the apoptosis pathway was upregulated in colons of mice lacking PPAR γ in T 
cells.
Conclusions: The expression of PPAR γ in T cells is involved in preventing gut inflammation by regulating colonic 
expression of adhesion molecules and inflammatory mediators at later stages of disease while favoring the recruitment 
of Treg to the mucosal inductive sites.
Background
Inflammatory bowel disease (IBD), with its two clinical
manifestations Crohn's Disease (CD) and Ulcerative Coli-
tis (UC), is a widespread and debilitating disease charac-
terized by inflammation and immune cell infiltration and
immune-mediated destruction of the gastrointestinal
tract [1]. Activation of the nuclear receptor peroxisome
proliferator-activated receptor γ (PPAR γ) has demon-
strated efficacy in reducing the severity of IBD by sup-
pressing excessive immunoinflammatory responses [2-4].
In the gut, PPAR γ is highly expressed in epithelial cells,
macrophages, and T-cells [5], and its activation has been
shown to repress nuclear factor-κB (NF-κB)-mediated
inflammation and promote a regulatory, anti-inflamma-
tory phenotype [2,6,7].
Our laboratory has shown that the deficiency of PPAR γ
in hematopoietic and epithelial cells significantly impairs
the ability of a naturally occurring PPAR γ ligand, conju-
gated linoleic acid, to improve inflammatory bowel dis-
ease [2,8,9], or inflammation-driven colorectal cancer
[10]. However, it remains unclear how these effects are
mediated through macrophages, T cells, epithelial cells,
or a combination of cells in the intestinal lamina propria,
mesenteric lymph nodes (MLN) and circulating lympho-
cytes. The role of PPAR γ in epithelial cells was examined
by Adachi et al, who found that the deficiency of PPAR γ
resulted in significantly worsened disease activity and
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enhanced levels of pro-inflammatory cytokines interleu-
kin 6 (IL-6) and IL-1β following DSS-induced colitis [11].
Mohapatra et al also demonstrated that mice lacking
PPAR γ in intestinal epithelial cells show upregulated
expression of genes in the lysosomal pathway [12]. Shah
and others demonstrated that the deficiency PPAR γ in
macrophages also worsens DSS colitis [13]. However, the
importance of T cell PPAR γ in the pathogenesis of IBD is
less understood.
The DSS colitis model targets initially epithelial cells
and macrophages, but there is a definite T cell involve-
m e n t  a t  l a t e r  s t a g e s  o f  d i s e a s e  [ 1 4 ] .  R e g u l a t o ry  T  c e l l
(Treg) PPARγ is involved in maintaining homeostasis at
the gastrointestinal tract [15,16] and preventing chronic
CD4+ T cell-induced colitis [17]. Thus, Treg represent an
important target of endogenous and exogenous PPAR γ
ligands. The objective of this study was to perform a com-
prehensive time course analysis of the effect of T cell-spe-
cific deletion of PPAR γ on the development of
experimental IBD by using a systems approach aimed at
examining immune cell distribution, global colonic gene
expression and gut immunopathology.
Methods
Animal Procedures
PPAR γ flfl; CD4Cre+ (CD4cre, n = 34) and Cre-wild-type
mice (WT, n = 34) in C57BL/6J background were used for
these experiments. The CD4cre mice (kindly provided by
Dr. R.B. Clark, University of Connecticut) express a
transgenic recombinase under the control of the CD4-
Cre promoter [18]. Since all T cell precursors express the
CD4 co-receptor at the thymic level (during the double-
positive thymocyte stage), the PPAR γ gene is deleted
from both CD4+ and CD8+ T cells. The mice were housed
at the animal facilities at Virginia Polytechnic Institute
and State University in a room maintained at 75°F, with a
12:12 h light-dark cycle starting from 6:00 AM. All exper-
imental procedures were approved by the Institutional
Animal Care and Use Committee of Virginia Polytechnic
Institute and State University and met or exceeded
requirements of the Public Health Service/National Insti-
tutes of Health and the Animal Welfare Act. Mice were
challenged with 2.5% dextran sodium sulfate (DSS),
36,000-44,000 molecular weight (ICN Biomedicals,
Aurora, OH) in the drinking water. After the DSS chal-
lenge mice were weighed on a daily basis and examined
for clinical signs of disease associated with colitis (i.e.,
perianal soiling, rectal bleeding, diarrhea, and piloerec-
tion). For the DSS challenge, the disease activity indices
and rectal bleeding scores were calculated using a modifi-
cation of a previously published compounded clinical
score [2]. Briefly, disease activity index consisted of a
scoring for diarrhea and lethargy (0-3), whereas rectal
bleeding consisted of a visual observation of blood in
feces and the perianal area (0-4). Mice in the DSS study
were euthanized on days 0, 2, and 7 of the DSS challenge
by carbon dioxide narcosis followed by secondary thorac-
otomy and blood was withdrawn from the heart. Spleen
and mesenteric lymph nodes (MLN) were scored based
on size and macroscopic inflammatory lesions (0-3),
excised, and single-cell suspensions were prepared as pre-
viously described [17] for flow cytometry.
Histopathology
Colonic sections were fixed in 10% buffered neutral form-
alin, later embedded in paraffin, and then sectioned (5
μm) and stained with hematoxylin and eosin (H&E) for
examination of microscopic lesions and changes in the
mucosal architecture. Colons were graded with a com-
pounded histologic score including the extent of (1) leu-
kocyte infiltration, (2) mucosal thickening, and (3)
epithelial cell erosion. The sections were graded with a
score of 0-4 for each of the previous categories and data
were analyzed as a normalized compounded score. Five
fields per tissue and 11 mice per time point were exam-
ined.
Immunophenotyping of blood, spleen, and mesenteric 
lymph nodes
MLN and spleen-derived cells or whole blood were
seeded onto 96-well plates, centrifuged at 4°C at 3000
rpm for 4 minutes, and washed with PBS containing 5%
serum and 0.09% sodium azide (FACS buffer). To assess
differential monocyte/macrophage subsets, the cells were
then incubated in the dark at 4°C for 20 minutes in
FcBlock (20 μg/ml; BD Pharmingen), and then for an
additional 20 minutes with fluorochrome-conjugated pri-
mary antibodies anti-F4/80-PE-Cy5 (5 μg/mL, ebiosci-
ence) and anti-CD11b-Alexa Fluor 700 (2 μg/mL,
eBioscience). For lymphocyte subset assessment, cells
were incubated with anti-CD4-Alexa Fluor 700 (2 μg/mL;
BD Pharmingen), anti-CD8-PerCp-Cy5.5 (2 μg/mL, eBio-
science), CD3 PE-Cy5 (2 μg/mL; BD Pharmingen), anti-
FoxP3-PE (2 μg/mL, eBioscience), and anti-IL10-PE as
previously shown [19]. Flow results were computed with
a BD LSR II flow cytometer and data analyses was per-
formed with FACS Diva software (BD).
Microarray data analysis
After homogenization of tissue, total RNA was extracted
and purified using the RNAeasy system according to
manufacturer's instructions (Qiagen Valencia, CA). The
QIAGEN RNase-free DNase supplement kit was used to
ensure that the RNA was free from DNA contamination.
RNA was then processed and labeled according to the
standard target labeling protocols and the samples were
hybridized, stained, and scanned per standard Affymetrix
protocols at VBI core laboratory on Mouse 430 2.0
expression arrays (Affymetrix Inc., Santa Clara, CA). AllGuri et al. BMC Gastroenterology 2010, 10:60
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statistical analysis of the data was performed within R
statistical environment - Version 2.9.0 [20] using Biocon-
ductor packages [21]. Raw microarray data from CEL files
were read with 'affy' package [22] and pre-processed by
gcRMA algorithm (GC Robust Multiarray Average) that
performs the three steps: (i) adjustment of the gene
expression signal against the background caused by opti-
cal noise and non-specific binding, (ii) robust multi-array
normalization [23], and (iii) summarization of the probes
belonging to each probe set. The microarray data (both
raw and normalized) have been submitted at the Gene
Expression Omnibus. (GEO, http://
www.ncbi.nlm.nih.gov/geo/, Data set: GSE20523).
Gene Set Enrichment Analysis
All pathways listed at Kyoto Encyclopedia for Genes and
Genomes (Kyoto Encyclopedia of Genes and Genomes)
[24] were selected for analysis. Two approaches were
taken to find the KEGG pathways significantly affected by
DSS in CD4cre mice. In the first approach, a global search
was conducted to find the KEGG pathway most signifi-
cantly affected under the condition. The degree of differ-
ential regulation of a pathway in CD4cre (compared to
wild-type) mice after 7 days of DSS treatment was
derived from a collective differential regulation of the
member genes in that pathway, as described earlier [25].
Briefly, each KEGG pathway was assigned a score
depending on its degree and direction of modulation,
which represented changes in collective gene expression
across most genes in each pathway. Normal-normal plot
(QQ-plot) and permutation testing were conducted to
find the pathway with a value significantly different from
the rest of the pathways. In the second approach, the
genes differentially expressed on day 7 of DSS treatment,
as derived from pair-wise gene-level comparison between
day 7 post-DSS and no DSS in CD4cre mice, were
selected for exploring which KEGG pathways were over-
represented in this collection of genes. These included
both up-and down-regulated genes due to DSS. None of
these genes were differentially expressed in the wild-type
mice at corresponding time point (i.e., day 7) of DSS
treatment. Hypergeometric testing was performed on
this collection of genes to discover the over-represented
KEGG pathways. This procedure used Fisher's exact test
to find association between interesting genes (differen-
tially expressed at day 7 in CD4cre mice) and member-
ship to a KEGG pathway. Results from both approaches
were combined to list the KEGG pathways that are signif-
icantly modulated by DSS on day 7 in CD4cre mice.
KEGG pathway visualization
KEGG pathways found to be significantly associated with
DSS on day 7 in CD4cre mice were accessed using the
bioconductor package KEGGSOAP. Specific gene nodes
on each pathway were 'colored' according to the direction
of differential expression of that gene in CD4cre mice on
day 7 of DSS treatment: red if up-regulated, green if
down-regulated.
Quantitative Real-Time RT-PCR
To validate microarray results we used quantitative, real-
time, RT-PCR. Total RNA (1 μg) from colons was used to
generate a complementary DNA (cDNA) template using
the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA)
using previously described conditions [2]. Each gene
amplicon was purified with the MiniElute PCR Purifica-
tion Kit (Qiagen) and quantitated on an agarose gel by
using a DNA mass ladder (Promega). These purified
amplicons were used to optimize real-time PCR condi-
tions and to generate standard curves in the real-time
PCR assay. Primer concentrations and annealing temper-
atures were optimized for the iCycler iQ system (Bio-
Rad) for each set of primers using the system's gradient
protocol. PCR efficiencies were maintained between 92
and 105% and correlation coefficients above 0.98 for each
primer set during optimization and also during the real-
time PCR of sample DNA.
Complementary DNA (cDNA) concentrations for
genes of interest were examined by real-time quantitative
PCR using an iCycler IQ System and the iQ SYBR green
supermix (Bio-Rad). A standard curve was generated for
each gene using 10-fold dilutions of purified amplicons
starting at 5 pg of cDNA and used later to calculate the
starting amount of target cDNA in the unknown samples.
SYBR green I is a general double-stranded DNA interca-
lating dye and may therefore detect nonspecific products
and primer/dimers in addition to the amplicon of inter-
est. In order to determine the number of products syn-
thesized during the real-time PCR, a melting curve
analysis was performed on each product. Real-time PCR
was used to measure the starting amount of nucleic acid
of each unknown sample of cDNA on the same 96-well
plate.
Statistics
Flow cytometry, disease activity, pathology and real-time
RT-PCR data were analyzed as a completely randomized
design. To determine the statistical significance of the
model, analysis of variance (ANOVA) was performed
using the general linear model procedure of Statistical
Analysis Software (SAS), and probability value (P) < 0.05
was considered to be significant. When the model was
significant, ANOVA was followed by Fisher's Protected
Least Significant Difference multiple comparison
method. Statistical analysis for microarray analyses was
performed using the software package "limma" [26], for
pairwise comparisons (Day 2 post-DSS Vs. no DSS, Day 7
post-DSS Vs. no DSS). P-values for the comparisons ofGuri et al. BMC Gastroenterology 2010, 10:60
http://www.biomedcentral.com/1471-230X/10/60
Page 4 of 13
interest were obtained using empirical Bayes method [27]
and adjusting for multiple testing [28]. Venn Diagrams
were drawn to show the number of genes differentially
expressed due to DSS challenge at different time points
(days 2 or 7), in different mouse strains (WT or CD4cre)
and the genes commonly induced in both strains. A large
number of genes found to be differentially expressed on
day 7 of DSS challenge in CD4cre mice were further sub-
jected to hypergeometric testing [29] for identifying the
enriched KEGG [30] pathways as described in the Gene
Set Enrichment Analysis section.
Results
The loss of PPAR γ in T cells accelerates the onset of disease 
activity and body weight loss
WT or CD4cre mice were challenged with 2.5% DSS for 7
days to induce experimental IBD and to determine the
effect of T cell-specific deletion of PPAR γ on colitis
severity, gene expression and immune cell distribution.
Differences between the groups first appeared on day 4 of
the challenge, where CD4cre mice had significantly
greater body weight loss despite no significant difference
in disease activity (Figure 1A and 1B). The differences in
body weights were transient however, and by day 7 body
weights were relatively equal between groups.
To more closely examine the effect of T cell-specific
PPAR γ deletion on experimental IBD, colons were histo-
logically examined for the presence of inflammatory
lesions and scored (Figure 2). Our analysis indicated that
colons recovered from CD4cre mice had significantly
more epithelial erosion, leukocyte infiltration, and
mucosal thickness on day 7 compared to their WT coun-
terparts. As anticipated from a model that initially targets
epithelial cells and macrophages, no histological differ-
ences were found between WT and CD4cre mice on day
2. The leukocyte infiltration in the colon was polymor-
phonuclear and lymphoplasmacytic on day 2, but pro-
gressed towards a predominantly lymphoplasmacytic
infiltrate on day 7 of DSS colitis.
T cell-specific PPAR γ-deficient mice have more CD8+ T cells, 
and fewer CD4+ T cells and regulatory T cells
We next characterized the effect of T cell-specific PPAR γ
deletion on the distribution of immune cell subsets in the
blood, spleen, and MLN by using flow cytometry. In these
tissues the CD4cre mice showed a consistent increase in
the percent of CD8+ T cells and a decrease in the percent
of CD4+ T cells (Figure 3). The number of F4/80+CD11b+
monocytes/macrophages in these tissues was unaffected
by the deletion of PPAR γ in T cells (data not shown).
We also examined the percentages of regulatory T cells
and those expressing IL-10 in these tissues. On day 7,
blood from WT mice had significantly more CD4+FoxP3+
Tregs in comparison to blood from CD4cre mice. While
there were no significant differences in the number of
CD4+FoxP3+ cells in MLN (data not shown), the percent
of CD4+ T cells expressing IL-10 was significantly lower
in MLN of CD4cre mice in comparison to WT mice (Fig-
ure 3). These data suggest that the deficiency of PPAR γ
in T cells impairs the Treg-mediated immunoregulation.
Global gene expression analyses in the colonic mucosa of 
WT and T cell-specific PPAR γ null mice with DSS colitis
Pairwise comparisons revealed a transcriptional effect of
DSS in the colonic mucosa at both time points (Day 2 and
7), with some differences between the two mouse strains.
On day 2, there were more genes affected in WT (202)
compared to only 8 genes in CD4cre mice (Additional file
1: Supplemental Figure S1). However, the number of
genes transcriptionally altered was reduced from 200 to
39 in the WT mice on day 7. On the other hand, CD4cre
mice revealed a steep rise in the number of genes differ-
entially expressed in the later time point; from 8 on day 2
to 3036 on day 7 (Additional file 2: Supplemental Figure
S2). Since CD4cre and WT mice primarily differ in the
presence of T cell PPAR γ, the massive transcriptional
modulation on day 7 in CD4cre mice is likely caused by
functional changes in T cells derived from the deletion of
PPAR γ. Out of the 3036 genes differentially expressed on
d a y  7  i n  C D 4 c r e  m i c e ,  s o m e  g e n e s  w e r e  a l s o  a f f e c t e d
under other conditions with 2990 genes being uniquely
modulated on day 7 in CD4cre mice. Additionally, these
2990 genes included leukocyte extravasation markers and
pro-inflammatory cytokines described and validated by
real-time RT-PCR.
Leukocyte extravasation markers and inflammatory 
cytokines are upregulated in colons of T cell-specific PPAR 
γ-deficient mice
To determine the effect of T cell-specific PPAR γ-deletion
on colonic gene expression microarrays were performed
from mice on days 0, 2, and 7 of DSS challenge (Figure 4).
Leukocyte extravasation markers were significantly
enhanced in both WT and CD4cre mice throughout the
DSS challenge, though in comparing the two groups we
observed that levels were significantly greater in CD4cre
mice on day 7. Expression of integrin alpha V (intgav),
integrin beta 2 (intgb2), intracellular adhesion molecule
(ICAM-1), vascular cell adhesion molecule (VCAM-1),
and P-selectin were all significantly enhanced in CD4cre
mice compared to the WT mice.
We also examined the mRNA expression of pro-inflam-
matory cytokines in colons of WT and CD4cre mice.
Expression of interleukin 6 (IL-6) and IL-1β were signifi-
cantly higher in colons from CD4cre mice at day 7 (Figure
4). Levels of cytokine signaling 3 (SOCS-3), an inhibitoryGuri et al. BMC Gastroenterology 2010, 10:60
http://www.biomedcentral.com/1471-230X/10/60
Page 5 of 13
protein shown to increase in response to IL-6 that has
been shown to be enhanced in both human IBD and
murine models of the disease [31-33], was also signifi-
cantly upregulated in colons of CD4cre mice. Microarray
findings were validated with real time RT-PCR analyses
(Figure 5D-H).
The Krebs cycle and ribosome pathways are significantly 
downregulated in colons of T cell-specific PPAR γ null mice; 
while apoptosis is significantly upregulated
W e next examined the effect of T cell-specific PP AR γ
deletion using gene set enrichment analysis (GSEA) of
KEGG pathways. The following three KEGG pathways
were significantly differentially regulated as revealed by
Figure 1 Effect of T cell-specific PPAR γ deletion on disease severity. WT or CD4cre mice were treated with 2.5% dextran sodium sulfate (DSS) or 
water (no DSS) for 7 days. The disease activity index (DAI), a composite score reflecting clinical signs of the disease (i.e. perianal soiling, rectal bleeding, 
diarrhea, and piloerection) was assessed daily (A) and the average daily loss in body weights (B) throughout the 7 day DSS challenge was calculated. 
Data are represented as mean ± standard error. Points with different subscripts are significantly different (P < 0.05).
 Guri et al. BMC Gastroenterology 2010, 10:60
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hypergeometric testing on the 2990 genes differentially
expressed on day 7 of DSS treatment compared with no
DSS in CD4cre mice: citrate (TCA cycle) or Krebs cycle,
apoptosis and ribosomal pathways (Additional file 3: Sup-
plemental Figure S3). Additionally, ribosomal pathway
was found to be the most significantly down-regulated
pathway from an unbiased global search using all genes
(normal Q-Q plot and permutation testing). While many
genes of the Krebs cycle and ribosomal pathway were
down-regulated, those of apoptosis were upregulated
(Additional files 4, 5, 6: Supplemental Figures S4-6 and
Additional file 7: Supplemental Table S1). The Krebs
cycle pathway is involved in the maintenance of glucose
homeostasis, one of the primary roles of PPAR γ. The
apoptosis pathway is critically regulated by NF-κB which
is repressed by PPAR γ in IBD. However, the pathway
most significantly affected by the deletion of PPAR γ was
the ribosome pathway (Additional file 6: Supplemental
Figure S6), which controls genes involved in protein
translation and synthesis.
Figure 2 Effect of T cell-specific PPAR γ deletion on colon histopathology. WT or CD4cre mice were treated with 2.5% dextran sodium sulfate 
(DSS) or water (no DSS) for 7 days. Representative photomicrographs (40 ×) from wt, no-DSS (A), wt, DSS (B), CD4cre, no-DSS (C), and CD4cre, DSS (D) 
groups are depicted. All specimens underwent blinded histological examination and were scored (1-4) on epithelial erosion (E), leukocyte infiltration 
(F), and mucosal wall thickening (G) on days 0, 2, and 7 of DSS challenge. Data are represented as mean ± standard error. Points with an asterisk are 
significantly different at a given time point (P < 0.05).Guri et al. BMC Gastroenterology 2010, 10:60
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Figure 3 Effect of T cell-specific PPAR γ deletion on lymphocyte subsets in blood, spleen, and mesenteric lymph nodes (MLN). Blood (A-C), 
spleen (D-E), and MLN (F-H) from wild-type (WT) or PPAR γ flfl; CD4 Cre+ (CD4cre) mice were immunophenotyped with anti-CD3, anti-CD4, anti-CD8 
antibodies, anti-F4/80, anti-CD11b, anti-FoxP3, and anti-IL10 to identify immune subsets through flow cytometry. Data were collected on days 0, 2, 
and 7 of DSS challenge and was analyzed with FACS Diva software. Data are represented as mean ± standard error. Points with an asterisk are signif-
icantly different at a given time point (P < 0.05).
 
 Guri et al. BMC Gastroenterology 2010, 10:60
http://www.biomedcentral.com/1471-230X/10/60
Page 8 of 13
Discussion
Activation of PPAR γ by exogenous administration of
synthetic and naturally occurring agonists or through
gene therapy has demonstrated pre-clinical efficacy in the
prevention and treatment of gut inflammation [2,9,34-
37]. Accordingly, PPAR γ was proposed as a therapeutic
target for gastrointestinal inflammation. The results of a
recent randomized, double-blind, placebo controlled
study demonstrate that oral administration of rosiglita-
zone (Avandia), a synthetic PPAR γ ligand of the thiazoli-
dinedione class of anti-diabetic drugs, ameliorates
disease activity in human UC patients [4]. Thus, dissect-
ing the cell specificity of PPAR γ in the prevention and
treatment of gut inflammation is necessary for the ratio-
nal development of placebo-controlled clinical studies
aimed at investigating the efficacy and tolerability of
novel PPAR γ agonists in patients with IBD.
In this regard, PPAR γ is widely expressed in all major
cell types involved in the immunopathogenesis of IBD,
including T cells, macrophages, dendritic cells, endothe-
lial cells and epithelial cells. Previous studies have charac-
terized the impact of the PPAR γ deficiency in epithelial
cells in DSS colitis and demonstrated that while PPAR γ
expressed in the colonic epithelium has an endogenous
role in protection against colitis, rosiglitazone treatment
can ameliorate experimental IBD in epithelial cell-spe-
cific PPAR γ null mice [11]. Adding to this story, our labo-
ratory has recently shown that intestinal epithelial cell
specific deletion of PPAR γ enhances macrophage MHC
II expression in the MLN and lysosomal pathway gene
Figure 4 Effect of T cell-specific PPAR γ deletion on leukocyte extravasation markers. WT or CD4cre mice were treated with 2.5% dextran sodi-
um sulfate (DSS) for 7 days, and microarray analyses was performed. Colons of WT (A) and CD4cre (B) mice were assessed for leukocyte extravasation 
markers integrin alpha V (intgav), integrin alpha X (intgax), integrin beta 2 (intgb2), intracellular adhesion molecule 1 (ICAM-1), mucosal addressin ad-
hesion molecule 1 (MAdCAM-1), vascular adhesion molecule 1 (VCAM-1) and P-selectin. Results from microarray were validated with real time PCR. 
Points with an asterisk are significantly different from the day 0 time point (P < 0.05). Points with a double asterisk also indicate a significant difference 
due to genotype at a given time point (P < 0.05).
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Figure 5 Effect of T cell-specific PPAR γ deletion on inflammatory gene expression. WT or CD4cre mice were treated with 2.5% dextran sodium 
sulfate (DSS) for 7 days, and microarray analyses was performed on colon samples. Differences in interleukin 6 (IL-6) (A), IL-1β (B), and suppressor of 
cytokine signaling 3 (SOCS-3) (C) were compared among groups and validated with real time PCR. Expressions of (IL-6 (D), vascular adhesion molecule 
1 (VCAM-1) (E), intracellular adhesion molecule 1 (ICAM-1) (F), integrin alpha V (intgav) (G), and SOCS-3 (H) on days 0 and 7 were examined by real time 
PCR to validate microarray findings. Points with an asterisk are significantly different from the day 0 time point (P < 0.05). Points with a double asterisk 
also indicate a significant difference due to genotype at a given time point (P < 0.05).Guri et al. BMC Gastroenterology 2010, 10:60
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expression in the colon without significantly affecting
lymphocyte populations in the blood, spleen, and MLN
[12]. A targeted disruption of PPAR γ in macrophages
increased recruitment of macrophages to inflammatory
foci in the colon [13]. This report investigates the role of
endogenously activated T cell PPAR γ in experimental
IBD.
The initial phases of DSS colitis (i.e., day 2) target the
innate components of the immune response (i.e., mac-
rophages and epithelial cells), whereas T cells are
recruited at later stages of disease (days 4-7) following the
initial epithelial cell damage and macrophage activation.
We found that disease activity and body weights were
worsened in CD4cre mice at about the fourth day of DSS
challenge, indicating that disease progression is acceler-
a t e d  w h e n  P P A R  γ  i s  a b s e n t  i n  T  c e l l s.  H i s t o l o g i c a l l y ,
colonic inflammatory lesions were limited or null on day
2 whereas significant epithelial erosion and immune cell
infiltration was observed on day 7, which was more
severe in mice lacking PPAR γ in T cells. Of note, the
crosstalk between myeloid cells and lymphocytes repre-
sents an important component of disease progression
[38]. CD4+ T cells and CD4-induced production of IL-6
are both increased in the lamina propria of DSS-treated
mice [39,40], and the infiltration of CD4+ T cells into the
colon has been shown to correlate with gut immune-
mediated pathology [40].
Transcriptomic profiling of colonic samples revealed
that on day 2 of DSS colitis, corresponding to the period
of activation of innate immunity, there were 202 genes
affected in WT and only 8 genes in CD4cre mice. In con-
t r a s t ,  o n  d a y  7  w h e n  b o t h  i n n a t e  a n d  a c q u i r e d  T  c e l l
responses contribute to gut immunopathology, we found
a dramatic increase in the number of differentially
expressed genes (i.e., 3036) in colons of mice lacking
PPAR γ in T cells versus only 39 differentially expressed
genes in colons of WT mice. Specifically, on day 7 there
were significant increases in IL-6, IL-1β and SOCS3 in
colons of CD4cre mice. These proinflammatory cytok-
ines have been shown to accelerate the progression of
intestinal inflammation [41-43]. The SOCS3 pathway can
be induced by IL-6 and plays a down-regulatory role in
the development of intestinal inflammation by inhibiting
signal transducer and activator of transcription (STAT3)
activation and thereby suppressing expression of inflam-
matory cytokines [33]. Since STAT3 is highly tyrosine
phosphorylated in UC and CD patients [33], the upregu-
lation of SOCS3 represents an anti-inflammatory feed-
back loop. Microarray analysis also revealed a significant
increase in genes involved in leukocyte extravasation in
the CD4cre mice, a finding that is in line with the
increased leukocyte recruitment we observed in colons of
T cell-specific PPAR γ null mice. Both VCAM-1 and
ICAM-1 are adhesion molecules independently associ-
ated with IBD disease severity [44], and their upregula-
tion is associated with increased NF-κB activity and pro-
inflammatory cytokine secretion [45]. In total, these find-
ings indicate an enhanced pro-inflammatory milieu in
colons of CD4cre mice on day 7 of DSS colitis mediated
by increased expression of pro-inflammatory cytokines
and adhesion molecules.
GSEA of KEGG pathways demonstrated that there was
a significant downregulation of gene clusters involved in
the maintenance of glucose homeostasis (i.e., Krebs cycle)
and protein synthesis (ribosome pathway), but up-regula-
tion of the apoptosis pathway. Together these findings
indicate a dysregulated carbohydrate metabolism, sup-
pressed protein translation and altered programmed cell
d e a t h  i n  c o l o n s  o f  C D 4 c r e  m i c e  ( f o l d - c h a n g e  i n  g e n e
expression in Supplementary Table 2). In line with our
findings, carbohydrate and amino acid metabolism have
r e c e n t l y  b e e n  s h o w n  t o  b e  r e d u c e d  i n  c o l o n s  o f  I B D
patients [46]. Considering that one of the first discovered
roles of PPAR γ was the regulation of glucose homeosta-
sis [47], it is not surprising that the deficiency of PPAR γ
in T cells could cause a down-regulation of gene clusters
related to Krebs cycle. In turn, these reductions may have
also resulted from a generalized increase in the severity of
colonic inflammation caused by the deficiency of PPAR γ
in T cells, as pro-inflammatory cytokines can inhibit
Krebs cycle activity [48]. The apoptosis and protein syn-
thesis pathways are also largely influenced by inflamma-
tion. The apoptosis pathway is critically regulated by NF-
κB [49] which is thought to be repressed by PPAR γ in
experimental IBD [50], and protein synthesis is decreased
in the inflamed colon as a result of endoplasmic reticu-
lum (ER) stress and subsequent activation of the unfolded
protein response in mouse models of IBD [51]. Thus, the
pathways affected by the deficiency of PP AR γ may be
secondary to more severe colitis. ER stress is also associ-
ated with induction of apoptosis via activation of an ER
resident caspase (caspase-12) [52]. Further studies are
needed to investigate whether T cell PPAR γ regulates
mucosal inflammation by altering carbohydrate metabo-
lism, colonic cell apoptosis and protein synthesis and its
relation with ER stress.
CD4cre mice have significantly fewer CD4+FoxP3+
Tregs in blood and IL10-expressing CD4+ T cells in the
MLN on day 7 of DSS colitis in comparison to WT mice.
We have demonstrated that the accumulation of Treg in
the mucosal inductive sites (i.e., MLN) is associated with
prevention of chronic colitis caused by the adoptive
transfer of CD4+CD45RBhi T cells in SCID mice [17].
Our flow cytometry results indicate that T cell PPAR γ is
required for the maintenance of IL-10-producing CD4+ T
cells in MLN, where intestinal immune responses are reg-
ulated, thereby inhibiting IL-6 and IL-1β expression in
the gut mucosa during IBD. Specifically, the levels ofGuri et al. BMC Gastroenterology 2010, 10:60
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IL10-expressing CD4+ T cells may be low in CD4Cre
mice at the onset due to the lack of PPAR γ. Since regula-
tory responses are initiated in parallel with inflammatory
responses, MLN Tregs are likely to increase in response
to the DSS challenge, but their numbers may wane as
they are recruited towards the principal site of inflamma-
tion; the colonic mucosa.
Adding to what was known about the effect of epithelial
cell and macrophage-specific deletion of PPAR γ, our
findings indicate that T cell PPAR γ also plays a protective
role during the progression of DSS colitis, though to a
lesser degree as seen in epithelial cells and macrophages.
The lower impact observed with T cell PPAR γ fits with
previous findings indicating that epithelial cells and mac-
rophages are the primary inflammatory mediators during
acute DSS colitis. Because T cell-mediated inflammation
has been shown to be very influential in chronic stages of
the disease [38,53], it may be worthwhile to assess the
affect of T cell PPAR γ in chronic colitis models.
Conclusions
Our findings indicate that T cell PPAR γ dampens the
inflammatory response and tissue destruction in the later
stages of experimental IBD by down-modulating expres-
sion of inflammatory cytokines and adhesion molecules.
T cell PPAR γ is also important in regulating the relative
abundance CD8+ and CD4+ T cell subsets, including Treg
in the periphery and mucosal inductive sites.
List of abbreviations used
IBD: Inflammatory bowel disease; PP AR γ: peroxisome
proliferator-activated receptor γ; NF-κB: nuclear factor
κB; DSS: dextran sodium sulphate; Treg: regulatory T cell;
MLN: mesenteric lymph node; intgav: integrin alpha V;
intgb2: integrin beta 2; ICAM-1: intracellular adhesion
molecule 1; VCAM-1: vascular adhesion molecule 1; IL:
interleukin; SOCS-3: suppressor of cytokine signalling 3;
intgax: integrin alpha X; MAdCAM-1: mucosal addessin
adhesion molecule 1.
Additional material
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
AJG analyzed data, summarized flow cytometry results, performed real-time
RT-PCR and contributed to write the manuscript. SKM performed the microar-
ray analyses and contributed to write the manuscript. WTH performed mouse
studies and contributed to flow cytometry data acquisition and analysis, and
performed RNA isolation. JBR and RH designed the experiments, obtained
funding for this project, managed the project and wrote the manuscript.
Acknowledgements
JB-R, AJG, WTH and RH were supported in part by award number 
5R01AT004308 of the National Institutes of Health awarded to J.B.-R. Supported 
by funds of an Exploratory Virginia Bioinformatics Institute grant and funds 
from the Nutritional Immunology and Molecular Nutrition Laboratory. All 
authors have read and approved the final manuscript.
Author Details
Nutritional Immunology and Molecular Nutrition Laboratory, Virginia 
Bioinformatics Institute, Virginia Polytechnic Institute and State University, 
Blacksburg, VA 24061, USA
Additional file 1 Venn diagram showing number of genes differen-
tially expressed on day 2 of DSS challenge. The number inside each cir-
cle refers to number of genes differentially expressed on 2nd day of DSS 
challenge (compared to control, i.e., day 0), for each genotype (WT or 
CD4cre). The number inside overlapping region of two circles refers to the 
number of genes that are common to both genotypes.
Additional file 2 Venn diagram showing number of genes differen-
tially expressed on day 7 of DSS challenge. The number inside each cir-
cle refers to number of genes differentially expressed on 7th day of DSS 
challenge (compared to control, i.e., day 0), for each genotype (WT or 
CD4cre). The number inside overlapping region of two circles refers to the 
number of genes that are common to both genotypes.
Additional file 3 KEGG pathways modulated on day 7 of DSS chal-
lenge in CD4cre mice. A total of 2990 genes, transcriptionally affected only 
on day 7 of CD4cre mice (in no other condition), were subjected to hyper-
geometric testing and revealed enrichment (over-representation) of four 
KEGG pathways: Krebs cycle, amino sugars, apopotosis and ribosome path-
ways. The first and last columns correspond to the KEGG identifier and 
name of the pathway respectively. The second and third columns (Pvalue, 
OddsRatio) report that there is good association between DSS challenge 
and these pathways. The ExpCount records the expected number of genes 
in the selected gene list to be found at each tested KEGG pathway, which is 
exceeded by the actual Count (fifth column). Sixth column (Size) corre-
sponds to the total number of genes in that pathway. One of these path-
ways, 'apoptosis', is regulated by NF-κB that is repressed by PPARγ.
Additional file 4 Krebs (Citrate) cycle pathway from KEGG. A total of 
2990 genes, transcriptionally affected only in CD4cre mice on day 7 of dex-
tan sodium sulfate (DSS) challenge, were subjected to hypergeometric test-
ing for discovering the pathways significantly associated with DSS. Many 
genes participating in Krebs cycle were found to be down-regulated 
(painted green in this diagram).
Additional file 5 Apoptosis pathway from KEGG. A total of 2990 genes, 
transcriptionally affected only in CD4cre mice on day 7 of dextan sodium 
sulfate (DSS) challenge, were subjected to hypergeometric testing for dis-
covering the pathways significantly associated with DSS. Many genes par-
ticipating in apoptosis were found to be up-regulated (painted red in this 
diagram).
Additional file 6 Gene Set Enrichment Analysis 7 days post DSS (Ribo-
some pathway). Panel A Gene Set Enrichment Analysis (GSEA) was per-
formed on CD4cre and wild-type (WT) mice after 7 days of dextan sodium 
sulfate (DSS) challenge. The pathway "Ribosome" (KEGG Id: 03010) was 
found to have the lowest pathway score and significantly different from the 
other pathways, as observed on the Q-Q plot (not shown). Depicted here is 
a scatter plot in which each point corresponds to an expression signal for a 
gene belonging to this pathway. The line is a 45-degree diagonal. For most 
genes the expression values are less for CD4cre compared with WT (most 
points lie above the diagonal, i.e., lean toward WT), suggesting that this 
pathway is down-regulated in colonic mucosa of CD4cre mice on day 7 fol-
lowing DSS treatment. Panel B 2990 genes, transcriptionally affected only 
in CD4cre mice on day 7 of dextran sodium sulfate (DSS) challenge, were 
subjected to hypergeometric testing for discovering the pathways signifi-
cantly associated with DSS. Many genes participating in Ribosome were 
found to be down-regulated (painted green in this diagram).
Additional file 7 Supplemental Table S1 - Fold-change in gene 
expression after 7 days of Dextran Sodium Sulfate challenge in 
CD4cre mice. The genes belong to the three KEGG pathways: Krebs (Cit-
rate) cycle, Apoptosis and Ribosome.Guri et al. BMC Gastroenterology 2010, 10:60
http://www.biomedcentral.com/1471-230X/10/60
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